Loss of serotonergic function in carriers of PRKN mutations: a 11CDASB PET study

Key Points

• Impaired serotonergic function is observed in carriers of PRKN mutations, indicating significant neurobiological effects.
• The study utilized [11C]DASB PET imaging to assess serotonergic function, providing critical insights into dopamine transporters.
• Observational analysis highlights the connection between PRKN mutations and altered neurotransmission pathways, presenting a novel area for further research.
• Uncovering these alterations in serotonergic function calls for deeper investigations into therapeutic strategies for affected individuals.